Detecting ADRs in neonates can be challenging due to their limited ability to communicate symptoms. However, healthcare providers rely on:
Regular monitoring: Frequent assessment of vital signs, laboratory tests, and clinical symptoms. Parental reports: Parents and caregivers can provide valuable information about changes in the neonate's behavior or appearance. Pharmacovigilance programs: These programs collect and analyze data on drug safety, helping to identify potential ADRs.
